Proteomic characterisation of pancreatic islet β-cells stimulated with pancreatic carcinoma cell conditioned medium
- Shandong Medicinal Biotechnology Center, Shandong Academy of Medicinal Sciences, Key Laboratory for Biotech-Drugs Ministry of Health & Key Laboratory for Modern Medicine and Technology of Shandong Province, Jinan, Shandong Province, China
- Correspondence to Dr J Han, Shandong Medicinal Biotechnology Center, Shandong Academy of Medicinal Sciences, 89 Jingshi Road, Jinan, Shandong Province, P.R. China; jxhan9888{at}yahoo.com.cn
- Accepted 14 April 2009
- Published Online First 28 April 2009
Abstract
Aim: To characterise the protein expression profiles of pancreatic islet β-cells affected by cancer cells, and to identify the potential islet molecules related to pancreatic cancer-associated diabetes.
Methods: The cellular proteins of islet β-cell line INS-1 in response to conditioned medium (CM) prepared from pancreatic cancer cells were analysed using fluorescence-labelled 2D gel-based proteomics (2D-DIGE).
Results: 10 proteins were over-expressed and five were under-expressed in cancer CM-stimulated β-cells. Five differently expressed proteins were selected for further validation by Western blot analysis. HSP60 and peripherin, which have previously been reported to be associated with type 1 diabetes, and Prp19, a DNA repair protein, were up-regulated in INS-1 cells after cancer cell CM stimulation; HMOX1 and GRP78 were down-regulated. The islets adjacent to human pancreatic carcinomas showed increased peripherin expression than normal pancreatic islets.
Conclusion: These results provide new information regarding the regulation of protein expression in pancreatic cancer-associated diabetes.
Footnotes
-
Funding This work was supported by Key Project of Department of Science & Technology of Shandong Province, China (No.2005GG1102003).
-
Competing interests None.
-
Provenance and Peer review Not commissioned; externally peer reviewed.
-
Ethics approval Ethics approval was obtained.








